JP2008521908A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008521908A5 JP2008521908A5 JP2007544442A JP2007544442A JP2008521908A5 JP 2008521908 A5 JP2008521908 A5 JP 2008521908A5 JP 2007544442 A JP2007544442 A JP 2007544442A JP 2007544442 A JP2007544442 A JP 2007544442A JP 2008521908 A5 JP2008521908 A5 JP 2008521908A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- substituted
- group
- hydrogen
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 23
- 239000001257 hydrogen Substances 0.000 claims 23
- 125000001072 heteroaryl group Chemical group 0.000 claims 20
- 150000002431 hydrogen Chemical class 0.000 claims 19
- 125000001188 haloalkyl group Chemical group 0.000 claims 17
- 229910052736 halogen Inorganic materials 0.000 claims 17
- 150000002367 halogens Chemical class 0.000 claims 17
- 125000004438 haloalkoxy group Chemical group 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 13
- 125000003118 aryl group Chemical group 0.000 claims 12
- 150000001336 alkenes Chemical class 0.000 claims 11
- 150000001345 alkine derivatives Chemical group 0.000 claims 11
- 125000003710 aryl alkyl group Chemical group 0.000 claims 11
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 10
- 125000003107 substituted aryl group Chemical group 0.000 claims 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 125000001960 7 membered carbocyclic group Chemical group 0.000 claims 4
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 4
- 125000004423 acyloxy group Chemical group 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 4
- 150000002148 esters Chemical class 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 4
- 239000000651 prodrug Substances 0.000 claims 4
- 229940002612 prodrug Drugs 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000000547 substituted alkyl group Chemical group 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 3
- 102000008299 Nitric Oxide Synthase Human genes 0.000 claims 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 claims 2
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 claims 2
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 206010036376 Postherpetic Neuralgia Diseases 0.000 claims 2
- 230000005856 abnormality Effects 0.000 claims 2
- 230000001668 ameliorated effect Effects 0.000 claims 2
- 238000006471 dimerization reaction Methods 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 208000004296 neuralgia Diseases 0.000 claims 2
- 208000021722 neuropathic pain Diseases 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- 238000011200 topical administration Methods 0.000 claims 2
- 125000006164 6-membered heteroaryl group Chemical group 0.000 claims 1
- 229910003844 NSO2 Inorganic materials 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- FTTMCCMCBNEPQX-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-2-[2-(2-imidazol-1-yl-6-methylpyrimidin-4-yl)pyrrolidin-1-yl]ethanamine Chemical compound N=1C(C)=CC(C2N(CCC2)CCNCC=2C=C3OCOC3=CC=2)=NC=1N1C=CN=C1 FTTMCCMCBNEPQX-UHFFFAOYSA-N 0.000 claims 1
- ZJFFPGMGWOEQLF-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-n'-(3-imidazol-1-yl-1,2,4-thiadiazol-5-yl)-n'-methylpropane-1,3-diamine Chemical compound C=1C=C2OCOC2=CC=1CNCCCN(C)C(SN=1)=NC=1N1C=CN=C1 ZJFFPGMGWOEQLF-UHFFFAOYSA-N 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63197104P | 2004-12-01 | 2004-12-01 | |
| US67200105P | 2005-04-14 | 2005-04-14 | |
| PCT/US2005/043190 WO2006060424A2 (en) | 2004-12-01 | 2005-11-28 | Inducible nitric oxide synthase dimerization inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008521908A JP2008521908A (ja) | 2008-06-26 |
| JP2008521908A5 true JP2008521908A5 (enExample) | 2009-01-22 |
Family
ID=36215758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007544442A Pending JP2008521908A (ja) | 2004-12-01 | 2005-11-28 | 誘導型一酸化窒素シンターゼ阻害剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7825256B2 (enExample) |
| EP (1) | EP1817030A2 (enExample) |
| JP (1) | JP2008521908A (enExample) |
| KR (1) | KR20070084574A (enExample) |
| AR (1) | AR055287A1 (enExample) |
| AU (1) | AU2005311985A1 (enExample) |
| BR (1) | BRPI0518096A (enExample) |
| CA (1) | CA2589433A1 (enExample) |
| IL (1) | IL183392A0 (enExample) |
| TW (1) | TW200635587A (enExample) |
| WO (1) | WO2006060424A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070123572A1 (en) * | 2005-11-28 | 2007-05-31 | Kalypsys, Inc. | Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-amines |
| AU2006318223A1 (en) * | 2005-11-28 | 2007-05-31 | Kalypsys, Inc. | Imidazole derivatives as nitric oxide synthase dimerisation inhibitor |
| US20080293942A1 (en) * | 2005-11-28 | 2008-11-27 | Cousins Russell D | Methods of Preparing 2-Imidazol-1-Yl-4-Methyl-6-Pyrrolidin-2-Yl-Pyrimidine and 4-(1-Alkylpyrrolidin-2-Yl)-2-(1H-Imidazol-1-Yl)-6-Methylpyrimidine Derivatives |
| FR2903405B1 (fr) | 2006-07-04 | 2011-09-09 | Pasteur Institut | Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications |
| US20100055071A1 (en) * | 2006-11-21 | 2010-03-04 | Martin Robert Leivers | Anti-Viral Compounds |
| EP1939181A1 (en) * | 2006-12-27 | 2008-07-02 | sanofi-aventis | Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase |
| WO2008086176A2 (en) * | 2007-01-08 | 2008-07-17 | Kalypsys, Inc. | Topical pharmaceutical formulation comprising an inos inhibitor for the treatment of disease |
| JP2011510996A (ja) * | 2008-01-30 | 2011-04-07 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 新規ｓＥＨ阻害剤およびその使用 |
| US20100311776A1 (en) * | 2008-01-30 | 2010-12-09 | Smithkline Beecham Corporation | Novel sEH Inhibitors and their Use |
| US8578892B2 (en) * | 2008-06-13 | 2013-11-12 | Air Products And Chemicals, Inc. | Oxygen control system for oxygen enhanced combustion of solid fuels |
| US8478446B2 (en) | 2008-06-13 | 2013-07-02 | Air Products And Chemicals, Inc. | Oxygen control system for oxygen enhanced combustion |
| JP2015180606A (ja) * | 2012-08-01 | 2015-10-15 | アステラス製薬株式会社 | 抗癌剤の併用による癌治療方法 |
| KR102755267B1 (ko) | 2014-04-08 | 2025-01-15 | 더 메서디스트 하스피틀 | iNOS-억제 조성물들 및 이들의 유방암 치료제로서의 용도 |
| EP3166938A4 (en) | 2014-07-11 | 2018-01-17 | Northwestern University | 2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase |
| JP6460382B2 (ja) * | 2014-11-28 | 2019-01-30 | 株式会社豊田自動織機 | 飽和ヘテロ環含有化合物、並びにこれを用いた二次電池用電極及び二次電池、結着剤、蛍光物質 |
| GB201512635D0 (en) | 2015-07-17 | 2015-08-26 | Ucl Business Plc | Uses of therapeutic compounds |
| JP7153653B2 (ja) | 2017-02-14 | 2022-10-14 | リサーチ トライアングル インスティテュート | プロリン系神経ペプチドｆｆ受容体モジュレーター |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1161237B (it) | 1983-04-26 | 1987-03-18 | Montedison Spa | 1,4-dichetoni-insaturi ad attivita' fungicida |
| DE3433953A1 (de) * | 1984-09-15 | 1986-03-27 | A. Nattermann & Cie GmbH, 5000 Köln | Neue, eine imidazol-gruppe enthaltende 3,4-dihydro-2(1h)-pyridone und2(1h)-pyridone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| US5795905A (en) | 1995-06-06 | 1998-08-18 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| DE19541146A1 (de) * | 1995-10-25 | 1997-04-30 | Schering Ag | Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren |
| US5874452A (en) * | 1996-04-03 | 1999-02-23 | Merck & Co., Inc. | Biheteroaryl inhibitors of farnesyl-protein transferase |
| CZ294348B6 (cs) | 1996-05-31 | 2004-12-15 | Allelix Neuroscience Inc. | Substituovaný derivát glycinu a farmaceutický prostředek s jeho obsahem |
| DE19627310A1 (de) | 1996-06-27 | 1998-01-02 | Schering Ag | Imidazolderivate als Stickstoffmonoxid-Synthase-Inhibitoren |
| JP4495257B2 (ja) * | 1997-02-19 | 2010-06-30 | バーレツクス ラボラトリーズ インコーポレーテツド | Ｎｏｓ抑制剤としてのｎ−複素環誘導体 |
| US6432947B1 (en) * | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
| ID23510A (id) * | 1997-06-27 | 2000-04-27 | Bp Chem Int Ltd | Proses polimerisasi |
| US6861448B2 (en) * | 1998-01-14 | 2005-03-01 | Virtual Drug Development, Inc. | NAD synthetase inhibitors and uses thereof |
| US20030191279A1 (en) * | 1999-08-27 | 2003-10-09 | Goldstein Steven Wayne | Urea derivatives useful as anticancer agents |
| US6723743B1 (en) * | 1999-09-28 | 2004-04-20 | Neurogen Corporation | High affinity small molecule C5a receptor modulators |
| DE60039921D1 (de) | 2000-09-29 | 2008-09-25 | Neurogen Corp | Hochaffine kleinmolekülige c5a-rezeptor-modulatoren |
| DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| FR2827286A1 (fr) | 2001-07-11 | 2003-01-17 | Aventis Cropscience Sa | Nouveaux composes fongicides |
| WO2003082205A2 (en) | 2002-03-27 | 2003-10-09 | Smithkline Beecham Corporation | Compounds and methods |
| EP1490343A1 (en) | 2002-03-29 | 2004-12-29 | Neurogen Corporation | New aryl imidazoles and related compounds as c5a receptor modulators |
| JP2005530719A (ja) | 2002-03-29 | 2005-10-13 | ニューロジェン コーポレーション | 病原性炎症要素を有する状態の治療のための組み合わせ療法 |
| AR040847A1 (es) * | 2002-08-09 | 2005-04-20 | Astrazeneca Ab | 1,2,4-oxadiazoles como moduladores de receptores de glutamato metabotropicos, para el tratamiento de desordenes neurologicos y psiquiatricos |
| AU2003260033A1 (en) * | 2002-08-29 | 2004-03-19 | Schering Aktiengesellschaft | Methods of treating acute respiratory distress syndrome |
| PL378402A1 (pl) * | 2003-02-06 | 2006-04-03 | Basf Aktiengesellschaft | Pirymidyny, sposoby ich wytwarzania i ich zastosowanie |
| AU2006318223A1 (en) * | 2005-11-28 | 2007-05-31 | Kalypsys, Inc. | Imidazole derivatives as nitric oxide synthase dimerisation inhibitor |
-
2005
- 2005-11-28 WO PCT/US2005/043190 patent/WO2006060424A2/en not_active Ceased
- 2005-11-28 US US11/288,888 patent/US7825256B2/en not_active Expired - Fee Related
- 2005-11-28 BR BRPI0518096-1A patent/BRPI0518096A/pt not_active IP Right Cessation
- 2005-11-28 AR ARP050104970A patent/AR055287A1/es unknown
- 2005-11-28 CA CA002589433A patent/CA2589433A1/en not_active Abandoned
- 2005-11-28 TW TW094141754A patent/TW200635587A/zh unknown
- 2005-11-28 KR KR1020077011898A patent/KR20070084574A/ko not_active Withdrawn
- 2005-11-28 AU AU2005311985A patent/AU2005311985A1/en not_active Abandoned
- 2005-11-28 JP JP2007544442A patent/JP2008521908A/ja active Pending
- 2005-11-28 EP EP05852447A patent/EP1817030A2/en not_active Withdrawn
-
2007
- 2007-05-24 IL IL183392A patent/IL183392A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3759093B1 (en) | Compounds useful as immunomodulators | |
| CA2876690C (en) | Dihydropyrimidine compounds and their application in pharmaceuticals | |
| CN104903334B (zh) | 一种替诺福韦前药及其在医药上的应用 | |
| TWI354666B (en) | Heterocyclic aspartyl protease inhibitors | |
| AU2016316278B2 (en) | Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof | |
| JP2021534124A5 (enExample) | ||
| US20040259842A1 (en) | Intracellular calcuim concentration increase inhibitors | |
| AU2011293612B2 (en) | Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators | |
| AU2008307516B2 (en) | Method of treating polycystic kidney diseases with ceramide derivatives | |
| CN103249737A (zh) | 作为精氨酸酶抑制剂的硼酸盐 | |
| JP2017531038A5 (enExample) | ||
| JP2011509309A5 (enExample) | ||
| WO2005085241A1 (ja) | チアゾール誘導体 | |
| WO2007139150A1 (ja) | ＴＮＦα阻害物質を含有してなる抗インフルエンザウイルス剤 | |
| EA037587B1 (ru) | Способ получения противогрибковых соединений | |
| RU2014113539A (ru) | Тетрациклические гетероциклические соединения и способы их применения для лечения вирусных заболеваний | |
| JP2006507220A5 (enExample) | ||
| RU2008107733A (ru) | Ингибиторы gsk-3 | |
| JP5907077B2 (ja) | 二環式化合物およびその医薬用途 | |
| JP2005526773A5 (enExample) | ||
| RU2012129657A (ru) | Гетероциклические противовирусные соединения | |
| CN103387601A (zh) | 抗登革热病毒(denv)杂环肽类化合物及其制备方法和用途 | |
| TW201418250A (zh) | 含有雜環的５－羥基吲哚類衍生物及其用途 | |
| JP2023552862A5 (enExample) | ||
| JP2024504257A5 (enExample) |